Results
|
3601.
|
MiR-410 regulates MET to influence the proliferation and invasion of glioma. [electronic resource] by
- Chen, Lingchao
- Zhang, Junhe
- Feng, Yan
- Li, Ruiyan
- Sun, Xu
- Du, Wenzhong
- Piao, Xinyin
- Wang, Hanbing
- Yang, Dongbo
- Sun, Ying
- Li, Xianfeng
- Jiang, Tao
- Kang, Chunsheng
- Li, Yongli
- Jiang, Chuanlu
Producer: 20130326
In:
The international journal of biochemistry & cell biology vol. 44
Availability: No items available.
|
|
3602.
|
Rationale and design of MARQUEE: a phase III, randomized, double-blind study of tivantinib plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, nonsquamous, non-small-cell lung cancer. [electronic resource] by
- Scagliotti, Giorgio V
- Novello, Silvia
- Schiller, Joan H
- Hirsh, Vera
- Sequist, Lecia V
- Soria, Jean-Charles
- von Pawel, Joachim
- Schwartz, Brian
- Von Roemeling, Reinhard
- Sandler, Alan B
Producer: 20130131
In:
Clinical lung cancer vol. 13
Availability: No items available.
|
|
3603.
|
Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic. [electronic resource] by
- Jardim, Denis L F
- Tang, Chad
- Gagliato, Debora De Melo
- Falchook, Gerald S
- Hess, Kenneth
- Janku, Filip
- Fu, Siqing
- Wheler, Jennifer J
- Zinner, Ralph G
- Naing, Aung
- Tsimberidou, Apostolia M
- Holla, Vijaykumar
- Li, Marylin M
- Roy-Chowdhuri, Sinchita
- Luthra, Raja
- Salgia, Ravi
- Kurzrock, Razelle
- Meric-Bernstam, Funda
- Hong, David S
Producer: 20151117
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 20
Availability: No items available.
|
|
3604.
|
MET and ERBB2 are coexpressed in ERBB2+ breast cancer and contribute to innate resistance. [electronic resource] by
- Paulson, Amanda K
- Linklater, Erik S
- Berghuis, Bree D
- App, Colleen A
- Oostendorp, Leon D
- Paulson, Jayne E
- Pettinga, Jane E
- Melnik, Marianne K
- Vande Woude, George F
- Graveel, Carrie R
Producer: 20140318
In:
Molecular cancer research : MCR vol. 11
Availability: No items available.
|
|
3605.
|
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells. [electronic resource] by
- Troiani, Teresa
- Martinelli, Erika
- Napolitano, Stefania
- Vitagliano, Donata
- Ciuffreda, Loreta Pia
- Costantino, Sara
- Morgillo, Floriana
- Capasso, Anna
- Sforza, Vincenzo
- Nappi, Anna
- De Palma, Raffaele
- D'Aiuto, Elena
- Berrino, Liberato
- Bianco, Roberto
- Ciardiello, Fortunato
Producer: 20140826
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 19
Availability: No items available.
|
|
3606.
|
|
|
3607.
|
|
|
3608.
|
|
|
3609.
|
Alterations in EGFR and related genes following neo-adjuvant chemotherapy in Chinese patients with non-small cell lung cancer. [electronic resource] by
- Wang, Shuhang
- An, Tongtong
- Duan, Jianchun
- Zhang, Lijian
- Wu, Meina
- Zhou, Qinghua
- Chen, Jinfeng
- Zhuo, Minglei
- Yang, Lu
- Wang, Yuyan
- Bai, Hua
- Wang, Jie
Producer: 20130910
In:
PloS one vol. 8
Availability: No items available.
|
|
3610.
|
|
|
3611.
|
|
|
3612.
|
|
|
3613.
|
|
|
3614.
|
FOXM1 confers resistance to gefitinib in lung adenocarcinoma via a MET/AKT-dependent positive feedback loop. [electronic resource] by
- Wang, Yu
- Zhang, Weiwei
- Wen, Li
- Yang, Huiling
- Wen, Mingling
- Yun, Yuyu
- Zhao, Lisheng
- Zhu, Xiaofei
- Tian, Li
- Luo, Erping
- Li, Yu
- Liu, Wenchao
- Wen, Ning
Producer: 20180129
In:
Oncotarget vol. 7
Availability: No items available.
|
|
3615.
|
|
|
3616.
|
|
|
3617.
|
|
|
3618.
|
|
|
3619.
|
Depleting MET-Expressing Tumor Cells by ADCC Provides a Therapeutic Advantage over Inhibiting HGF/MET Signaling. [electronic resource] by
- Hultberg, Anna
- Morello, Virginia
- Huyghe, Leander
- De Jonge, Natalie
- Blanchetot, Christophe
- Hanssens, Valérie
- De Boeck, Gitte
- Silence, Karen
- Festjens, Els
- Heukers, Raimond
- Roux, Benjamin
- Lamballe, Fabienne
- Ginestier, Christophe
- Charafe-Jauffret, Emmanuelle
- Maina, Flavio
- Brouckaert, Peter
- Saunders, Michael
- Thibault, Alain
- Dreier, Torsten
- de Haard, Hans
- Michieli, Paolo
Producer: 20151124
In:
Cancer research vol. 75
Availability: No items available.
|
|
3620.
|
Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells. [electronic resource] by
- Vengoji, Raghupathy
- Macha, Muzafar A
- Nimmakayala, Rama Krishna
- Rachagani, Satyanarayana
- Siddiqui, Jawed A
- Mallya, Kavita
- Gorantla, Santhi
- Jain, Maneesh
- Ponnusamy, Moorthy P
- Batra, Surinder K
- Shonka, Nicole
Producer: 20191202
In:
Journal of experimental & clinical cancer research : CR vol. 38
Availability: No items available.
|